Urinary Incontinence
📧 Sign up to get email alerts when something new happens for Urinary Incontinence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-01-06FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved the supplemental application for oxybutynin chloride submitted by Strides Pharma Science Limited. The approval covers changes a…
-
CLINICAL_TRIALS research · 2008-10-17Clinical Trial Update: Trial Evaluating Transvaginal Electrical Stimulation With a Home Use Programmable Device for Urinary Stress Incontinence [Phase 2]
Phase 2 clinical trial evaluating a home-use transvaginal electrical stimulation device for urinary stress incontinence. The status of the t…
-
CLINICAL_TRIALS trial_result · 2008-10-03Clinical Trial Update: Assessment of Pelvic Floor Function in Elderly
A completed clinical trial evaluating pelvic floor function in elderly individuals with urinary incontinence.
-
FDA approval · 2008-09-11FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate filed by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2008-08-07Clinical Trial Update: Obstetrical Risk Factors for the Development of Urinary and/or Fecal Incontinence
This clinical trial update discusses obstetric risk factors that may contribute to developing urinary and/or fecal incontinence.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Programmable Timer in the Bladder Rehabilitation Treatment of OAB [NA]
A clinical trial update indicating the study on a programmable timer for bladder rehabilitation in overactive bladder and urinary incontinen…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Surface Nerve Stimulation Treatment for OAB in Children [NA]
A clinical trial evaluating surface nerve stimulation for pediatric overactive bladder and urinary incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-16Clinical Trial Update: Predictive Objective Parameters for Outcome of the Treatment of Stress Urinary Incontinence
Clinical trial update reporting predictive objective parameters for the outcome of treatment of urinary incontinence. The study status is co…
-
CLINICAL_TRIALS trial_result · 2008-01-29Clinical Trial Update: Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence [Phase 3]
Phase 3 clinical trial of propiverine in children with non-neurogenic overactive bladder and urinary incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-24Clinical Trial Update: Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder [Phase 4]
Phase 4 clinical trial sponsored by Novartis evaluated darifenacin with behavioral therapy for symptoms of overactive bladder and has comple…
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Pelvic Organ Prolapse Repair With or Without Concomitant Burch Colposuspension in Patients With Urinary Incontinence [NA]
This completed clinical trial evaluated pelvic organ prolapse repair with and without concomitant Burch colposuspension in women with urinar…
-
CLINICAL_TRIALS research · 2007-11-27Clinical Trial Update: The Immune Reactivity of Biofilms in Vaginal Mesh Erosion. [NA]
A clinical trial update investigating the immune reactivity of biofilms in vaginal mesh erosion, with the study status listed as UNKNOWN.
-
CLINICAL_TRIALS research · 2007-09-17Clinical Trial Update: Burden of Urinary Incontinence in Home Care Patients in the State of Geneva
A clinical trial update examining the burden of urinary incontinence among home care patients in the State of Geneva, sponsored by Universit…
-
CLINICAL_TRIALS trial_result · 2007-08-08Clinical Trial Update: ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) [Phase 2]
A Phase 2 randomized trial comparing ELB245 to tolterodine in patients with incontinent overactive bladder was terminated.
-
CLINICAL_TRIALS trial_result · 2007-07-31Clinical Trial Update: Promoting Effective Recovery From Labor Urinary Incontinence (PERL) [Phase 3]
Phase 3 clinical trial PERL evaluating recovery from labor-related urinary incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2007-07-25Clinical Trial Update: Promoting Self Care to Prevent Urinary Incontinence (UI): A Four-Year Follow-up [Phase 3]
A four-year follow-up report from a Phase 3 trial evaluating self-care interventions to prevent urinary incontinence.
-
CLINICAL_TRIALS research · 2007-06-22Clinical Trial Update: Measurement of Vaginal Squeeze Pressure in Incontinent Patients
Clinical trial update focusing on measuring vaginal squeeze pressure in incontinent patients; no results or regulatory status reported.
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Urge Incontinence Bladder Overactivity Study [Phase 2]
A Phase 2 clinical trial for urge incontinence and bladder overactivity has completed.
-
CLINICAL_TRIALS research · 2007-05-17Clinical Trial Update: Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity
This document describes a safety and applicability study of a novel heat-flow sensor unit intended to measure urinary bladder capacity. The …
-
FDA approval · 2007-04-24FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Vesicare (solifenacin succinate) from Astellas Pharma US, Inc. under NDA 021518.
-
FDA approval · 2007-03-16FDA Approved: DETROL LA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DETROL LA (tolterodine tartrate) from Viatris Specialty LLC.
-
FDA approval · 2007-03-16FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for tolterodine tartrate submitted by Mylan Pharmaceuticals Inc., updating the product's labelin…
-
FDA approval · 2007-02-01FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for oxybutynin chloride (Strides Pharma Science Limited) under ANDA075079. This action authorizes th…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence [Phase 3]
Phase 3 trial evaluating duloxetine for predominant stress urinary incontinence has completed; the snippet does not report results.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence [Phase 3]
Phase 3 trial evaluating the biomechanical and electrophysiological effects of duloxetine in women with urinary stress incontinence has comp…